News

Extreme heat can be life-threatening for pets. Follow these vet-approved tips to keep your pet safe during scorching ...
A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the Food and Drug Administration (FDA).
The FDA has approved a long-acting drug to protect dogs against fleas and ticks. The drug, Bravecto Quantum, is given by injection and must be prescribed by a licensed veterinarian.
FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.
Merck's animal health division received Food and Drug Administration approval for its once-yearly injectable flea-and-tick treatment for dogs. Merck Animal Health said Thursday it expects its Bravecto ...
TruCan Ultra CIV H3N2/H3N8 will broadly protect canine patients from canine influenza. Elanco Animal Health Incorporated ...
Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...
Behind every meal served to a soldier, sailor, airman, Guardian, or Marine, the U.S. Army Veterinary Corps is working hard to make sure that food is safe.
Vermilion Energy Inc. (“Vermilion”, “We”, “Our”, or the “Company”) (TSX: VET) (NYSE: VET) is pleased to announce that the Toronto Stock Exchange (“TSX”) has ...
In Ireland, to evaluate official controls and enforcement of EU requirements, the auditors met with FSAI (Food Safety ...